We are live on
!
Find out more
Sarepta Therapeutics
SRPT
SRPT
344 hedge funds and large institutions have $2.01B invested in Sarepta Therapeutics in 2025 Q4 according to their latest regulatory filings, with 72 funds opening new positions, 136 increasing their positions, 90 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 43
51% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 90
20% more capital invested
Capital invested by funds: $1.67B → $2.01B (+$339M)
8% more funds holding
Funds holding: 319 → 344 (+25)
0.3% more ownership
Funds ownership: 88.83% → 89.13% (+0.3%)
16% less call options, than puts
Call options by funds: $114M | Put options by funds: $136M
Holders
344
Holders Change
+25
Holders Change %
+7.84%
% of All Funds
4.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
72
Increased
136
Reduced
90
Closed
43
Calls
$114M
Puts
$136M
Net Calls
-$22M
Net Calls Change
-$11.9M
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$135M |
| 2 |
State Street
Boston,
Massachusetts
|
+$27.3M |
| 3 |
BlackRock
New York
|
+$22.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$18.8M |
